Wilson Vinny, Kaur Prabhjit, Singh Sofia, Ramachandran Radhika P, Jyothi Vislavath, Mahesh Karthik V, Takkar Aastha, Chandak Giriraj, Singh Ramandeep
Department of Neurology, Armed Forces Medical College, Pune, Maharashtra, India.
Department of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Ann Indian Acad Neurol. 2022 Oct;25(Suppl 2):S65-S69. doi: 10.4103/aian.aian_532_22. Epub 2022 Oct 19.
Leber hereditary optic neuropathy (LHON) is a maternally inherited disease resulting in irreversible visual loss usually in patients belonging to the age group of 15-35 years. Clinically, the patients present with sequential or bilateral, painless, progressive visual loss with central (or ceco-central) scotomas. Although the three mutations, namely, G11778A, T14484C, and G3460A contribute to >95% of LHON cases globally, the relative frequency of each mutation varies.
We aimed to assess the clinical and genetic profile of patients with mutation-positive LHON at a north Indian tertiary care center.
One hundred sixty-one patients (61 prospective and 100 retrospective) presenting with the clinical diagnosis of LHON were screened for the three known mitochondrial mutations (G1178A, G3460A, T14448C). Patients were assessed for detailed clinical, ophthalmological, and neurological examinations. Five milliliter of blood sample was taken to assess the three known mutations using DNA isolation and Sanger sequencing.
Clinical profile of 83 patients with both positive and negative mutations was analyzed. Twenty-three out of 161 patients (14.3%) tested positive for either of the three mutations. The majority of the patients harbored G11778A mutation (56.52%) followed by T14484C (34.78%) and G3460A (8.69%). No statistical difference could be noted between the clinical profiles of mutation-negative and -positive patients.
Leber遗传性视神经病变(LHON)是一种母系遗传疾病,通常导致15至35岁年龄组患者出现不可逆的视力丧失。临床上,患者表现为相继或双侧无痛性进行性视力丧失,并伴有中心(或旁中心)暗点。尽管三种突变,即G11778A、T14484C和G3460A在全球LHON病例中占比超过95%,但每种突变的相对频率有所不同。
我们旨在评估印度北部一家三级医疗中心突变阳性LHON患者的临床和基因特征。
对161例临床诊断为LHON的患者(61例前瞻性和100例回顾性)进行三种已知线粒体突变(G1178A、G3460A、T14448C)的筛查。对患者进行详细的临床、眼科和神经学检查。采集5毫升血液样本,通过DNA分离和桑格测序评估三种已知突变。
分析了83例突变阳性和阴性患者的临床特征。161例患者中有23例(14.3%)三种突变中的任何一种检测呈阳性。大多数患者携带G11778A突变(56.52%),其次是T14484C(34.78%)和G3460A(8.69%)。突变阴性和阳性患者的临床特征之间未观察到统计学差异。